Search Results 161-170 of 19658 for ast

1. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

   Total bilirubin ≤ 1.5 x IULN or ≤ 3.0 x IULN with normal AST and ALT in patients with Gilbert's disease; AST(SGOT)/ALT(SGPT) ≤ 2.5 x IULN; Creatinine ...

2. Omega-3 Fatty Acids To Combat Sarcopenia - Mayo Clinic

   Chronic active liver disease (Bilirubin > 17mmol/L, AST>144IU/L, or ALT>165IU/L); Anti-coagulant therapy (warfarin/heparin); INR >3; Use of systemic ...

3. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < 2.5 ... AST (≤ 2.5 x ULN) = ______; ULN = ______. ALT (≤ 2.5 x ULN) = ______ ...

4. Fatty liver disease (MASLD) - Doctors and departments - Mayo Clinic

   Aspartate aminotransferase (AST) blood test · CT scan · Liver function tests · Magnetic resonance elastography · MELD (model for end-stage liver disease) score ...

5. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

   ... Ast...rocytoma, Oligodendroglioma, Neurofibromatosis, Glioma, Ependymoma, Spinal cord tumor, Peripheral nerve tumor, Neurofibroma, Plexiform neurofibroma ...

6. Hepatitis B - Doctors and departments - Mayo Clinic

   Aspartate aminotransferase (AST) blood test · Liver biopsy · Liver function tests · Liver transplant · MELD (model for end-stage liver disease) score. Show more ...

7. A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

   as AST, ALT, gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), or serum bilirubin in the presence of normal serum creatine kinase (CK). 2 ...

8. A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment - Mayo Clinic

   50 < AST < 400 IU/L;; ALT < 400 IU/L;; AST/ALT > 1.5. Maddrey's discriminant function ≥ 32 assuming a control prothrombin time of 12 seconds. Model for End ...

9. A Study to Evaluate the Effectiveness and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES) - Mayo Clinic

   ALT or AST level ≥ 3 × ULN during the screening period (AST or ALT \> 5 × ULN if documented HES with liver manifestations). Transient increase of AST/ALT ...

10. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Ast...rocytoma, Oligodendroglioma, Neurofibromatosis, Glioma, Ependymoma, Spinal cord tumor, Peripheral nerve tumor, Neurofibroma, Plexiform neurofibroma ...